| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 4.98e-05 | 3 | 82 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | beta-galactosidase activity | 1.65e-04 | 5 | 82 | 2 | GO:0004565 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 3.45e-04 | 7 | 82 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | galactosidase activity | 3.45e-04 | 7 | 82 | 2 | GO:0015925 | |
| GeneOntologyMolecularFunction | phospholipid binding | 4.09e-04 | 548 | 82 | 9 | GO:0005543 | |
| Domain | Glyco_hydro_35_CS | 1.77e-05 | 2 | 79 | 2 | IPR019801 | |
| Domain | Galactose-bd-like | 4.87e-05 | 94 | 79 | 5 | IPR008979 | |
| Domain | FBA_I | 5.29e-05 | 3 | 79 | 2 | IPR000741 | |
| Domain | Glycolytic | 5.29e-05 | 3 | 79 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 5.29e-05 | 3 | 79 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 5.29e-05 | 3 | 79 | 2 | PS00158 | |
| Domain | Glyco_hydro_35 | 1.05e-04 | 4 | 79 | 2 | PF01301 | |
| Domain | Gly_Hdrlase_35_cat | 1.05e-04 | 4 | 79 | 2 | IPR031330 | |
| Domain | Glycoside_Hdrlase_35 | 1.05e-04 | 4 | 79 | 2 | IPR001944 | |
| Domain | B-gal_1-like | 1.05e-04 | 4 | 79 | 2 | IPR026283 | |
| Domain | GLYCOSYL_HYDROL_F35 | 1.05e-04 | 4 | 79 | 2 | PS01182 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.56e-03 | 14 | 79 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.56e-03 | 14 | 79 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.56e-03 | 14 | 79 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.56e-03 | 14 | 79 | 2 | PF08393 | |
| Domain | MT | 1.56e-03 | 14 | 79 | 2 | PF12777 | |
| Domain | AAA_8 | 1.56e-03 | 14 | 79 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.56e-03 | 14 | 79 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.56e-03 | 14 | 79 | 2 | PF07728 | |
| Domain | DHC_fam | 1.79e-03 | 15 | 79 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.79e-03 | 15 | 79 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.79e-03 | 15 | 79 | 2 | PF03028 | |
| Domain | MAM_1 | 2.04e-03 | 16 | 79 | 2 | PS00740 | |
| Domain | MAM | 2.31e-03 | 17 | 79 | 2 | SM00137 | |
| Domain | MAM | 2.59e-03 | 18 | 79 | 2 | PF00629 | |
| Domain | MAM_dom | 2.59e-03 | 18 | 79 | 2 | IPR000998 | |
| Domain | MAM_2 | 2.59e-03 | 18 | 79 | 2 | PS50060 | |
| Domain | - | 3.66e-03 | 73 | 79 | 3 | 2.60.120.260 | |
| Domain | IG_LIKE | 4.72e-03 | 491 | 79 | 7 | PS50835 | |
| Domain | Ig-like_dom | 5.38e-03 | 503 | 79 | 7 | IPR007110 | |
| Domain | UBA | 7.12e-03 | 30 | 79 | 2 | SM00165 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.29e-05 | 271 | 65 | 8 | MM15406 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 5.06e-05 | 288 | 65 | 8 | M16864 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PDXDC1 FLII TECR NUP210 SNX27 CPNE1 MYO1B HUWE1 ATP2A1 SACM1L | 3.71e-06 | 647 | 84 | 10 | 26618866 |
| Pubmed | Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. | 5.76e-06 | 2 | 84 | 2 | 6208535 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27096746 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21651905 | ||
| Pubmed | 1.50e-05 | 20 | 84 | 3 | 15733084 | ||
| Pubmed | Mode of interactions of human aldolase isozymes with cytoskeletons. | 1.73e-05 | 3 | 84 | 2 | 9244396 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 32203496 | ||
| Pubmed | Ectopeptidases are differentially expressed in hepatocellular carcinomas. | 1.73e-05 | 3 | 84 | 2 | 14767532 | |
| Pubmed | Aldolase positively regulates of the canonical Wnt signaling pathway. | 1.73e-05 | 3 | 84 | 2 | 24993527 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17363457 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 16984256 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 14701874 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25614622 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11906289 | ||
| Pubmed | Renin-angiotensin system (RAS) enzymes and placental trophoblast syncytialisation. | 1.73e-05 | 3 | 84 | 2 | 35202745 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 6696436 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18263657 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 15283675 | ||
| Pubmed | Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development. | 3.45e-05 | 4 | 84 | 2 | 9510027 | |
| Pubmed | Neuronal position in the developing brain is regulated by mouse disabled-1. | 3.45e-05 | 4 | 84 | 2 | 9338785 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23410158 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9845246 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11399750 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11175280 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 16912050 | ||
| Pubmed | A novel mode of tangential migration of cortical projection neurons. | 5.74e-05 | 5 | 84 | 2 | 16901480 | |
| Pubmed | 6.41e-05 | 32 | 84 | 3 | 27806288 | ||
| Pubmed | 8.41e-05 | 35 | 84 | 3 | 20943929 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 27649628 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 25279712 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 32414784 | ||
| Pubmed | 1.16e-04 | 196 | 84 | 5 | 21862448 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 32913108 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 34517413 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 33057360 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 28408205 | ||
| Pubmed | An introduction of genetics in otosclerosis: a systematic review. | 2.05e-04 | 9 | 84 | 2 | 24170657 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 23523425 | ||
| Pubmed | Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae. | 2.31e-04 | 49 | 84 | 3 | 31609468 | |
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 2.56e-04 | 10 | 84 | 2 | 18989690 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 31768046 | ||
| Pubmed | Genome-wide association study of retinopathy in individuals without diabetes. | 2.56e-04 | 10 | 84 | 2 | 23393555 | |
| Pubmed | 3.07e-04 | 376 | 84 | 6 | 24154525 | ||
| Pubmed | Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. | 3.13e-04 | 11 | 84 | 2 | 31570706 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 35544642 | ||
| Pubmed | 3.52e-04 | 249 | 84 | 5 | 30097533 | ||
| Pubmed | CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. | 3.75e-04 | 12 | 84 | 2 | 21220099 | |
| Pubmed | Molecular logic of cellular diversification in the mouse cerebral cortex. | 3.75e-04 | 12 | 84 | 2 | 34163074 | |
| Pubmed | Dihydrofolate reductase activity controls neurogenic transitions in the developing neocortex. | 3.75e-04 | 12 | 84 | 2 | 37665322 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 36577717 | ||
| Pubmed | Rescuing lung development through embryonic inhibition of histone acetylation. | 3.75e-04 | 12 | 84 | 2 | 38295182 | |
| Pubmed | Pocket proteins pRb and p107 are required for cortical lamination independent of apoptosis. | 3.75e-04 | 12 | 84 | 2 | 24056077 | |
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 35942101 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 18596172 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 33622776 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 21768372 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 31749685 | ||
| Pubmed | Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. | 5.15e-04 | 14 | 84 | 2 | 21460838 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 5.26e-04 | 272 | 84 | 5 | 18187620 | |
| Pubmed | 5.69e-04 | 156 | 84 | 4 | 29961565 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 5.75e-04 | 974 | 84 | 9 | 28675297 | |
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 26439735 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 25556833 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 29901792 | ||
| Pubmed | 6.35e-04 | 69 | 84 | 3 | 32238831 | ||
| Pubmed | 6.55e-04 | 162 | 84 | 4 | 25826454 | ||
| Pubmed | Epithelial cells supply Sonic Hedgehog to the perinatal dentate gyrus via transport by platelets. | 6.77e-04 | 16 | 84 | 2 | 26457609 | |
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 31680851 | ||
| Pubmed | Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development. | 6.77e-04 | 16 | 84 | 2 | 35379703 | |
| Pubmed | PDGF signaling specificity is mediated through multiple immediate early genes. | 7.66e-04 | 17 | 84 | 2 | 17143286 | |
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 35361248 | ||
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 37590085 | ||
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 22411552 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 28272472 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 27320921 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 28049690 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 23056351 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 27412481 | ||
| Pubmed | Smad4 and Trim33/Tif1γ redundantly regulate neural stem cells in the developing cortex. | 8.60e-04 | 18 | 84 | 2 | 23765158 | |
| Pubmed | 9.60e-04 | 19 | 84 | 2 | 22095278 | ||
| Pubmed | 9.60e-04 | 19 | 84 | 2 | 20410112 | ||
| Pubmed | 9.60e-04 | 19 | 84 | 2 | 21052031 | ||
| Pubmed | 9.60e-04 | 19 | 84 | 2 | 33723434 | ||
| Pubmed | 9.60e-04 | 19 | 84 | 2 | 31345929 | ||
| Pubmed | PBX transcription factors drive pulmonary vascular adaptation to birth. | 9.60e-04 | 19 | 84 | 2 | 29251627 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 9.88e-04 | 313 | 84 | 5 | 38270169 | |
| Pubmed | Proneural genes define ground-state rules to regulate neurogenic patterning and cortical folding. | 1.06e-03 | 20 | 84 | 2 | 34407390 | |
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 22623674 | ||
| Pubmed | FOXG1 Orchestrates Neocortical Organization and Cortico-Cortical Connections. | 1.06e-03 | 20 | 84 | 2 | 30392794 | |
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 37272771 | ||
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 16774995 | ||
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 22542597 | ||
| Pubmed | Neddylation is critical to cortical development by regulating Wnt/β-catenin signaling. | 1.06e-03 | 20 | 84 | 2 | 33020269 | |
| Pubmed | ERK1 and ERK2 are required for radial glial maintenance and cortical lamination. | 1.17e-03 | 21 | 84 | 2 | 20825492 | |
| Pubmed | 1.17e-03 | 21 | 84 | 2 | 33739968 | ||
| Pubmed | 1.17e-03 | 21 | 84 | 2 | 19686682 | ||
| Pubmed | 1.29e-03 | 22 | 84 | 2 | 20506362 | ||
| Pubmed | 1.29e-03 | 22 | 84 | 2 | 33304758 | ||
| Pubmed | 1.35e-03 | 197 | 84 | 4 | 21386911 | ||
| Pubmed | HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | 1.37e-03 | 90 | 84 | 3 | 35671810 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP | 1.52e-05 | 98 | 83 | 5 | M11319 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP | 1.93e-05 | 103 | 83 | 5 | MM483 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-07 | 140 | 83 | 6 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-06 | 186 | 83 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.65e-06 | 193 | 83 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.92e-06 | 198 | 83 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.92e-06 | 198 | 83 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.03e-06 | 200 | 83 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-06 | 118 | 83 | 5 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 9.37e-06 | 151 | 83 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-05 | 155 | 83 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-05 | 155 | 83 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 167 | 83 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-05 | 169 | 83 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-05 | 169 | 83 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 176 | 83 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 177 | 83 | 5 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 177 | 83 | 5 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 179 | 83 | 5 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-05 | 181 | 83 | 5 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.31e-05 | 182 | 83 | 5 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.31e-05 | 182 | 83 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 182 | 83 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-05 | 182 | 83 | 5 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 182 | 83 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.43e-05 | 184 | 83 | 5 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-05 | 184 | 83 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.49e-05 | 185 | 83 | 5 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 83 | 5 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 83 | 5 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 83 | 5 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 83 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 186 | 83 | 5 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 186 | 83 | 5 | 1ed71b229f40a680071b14f5a7a19706e0fd14b1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 187 | 83 | 5 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.62e-05 | 187 | 83 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 187 | 83 | 5 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 187 | 83 | 5 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.69e-05 | 188 | 83 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.69e-05 | 188 | 83 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.69e-05 | 188 | 83 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.76e-05 | 189 | 83 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.76e-05 | 189 | 83 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.76e-05 | 189 | 83 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.76e-05 | 189 | 83 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.76e-05 | 189 | 83 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 191 | 83 | 5 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 191 | 83 | 5 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 191 | 83 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 191 | 83 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 191 | 83 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 192 | 83 | 5 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.98e-05 | 192 | 83 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-05 | 193 | 83 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.05e-05 | 193 | 83 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 193 | 83 | 5 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 193 | 83 | 5 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 194 | 83 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.13e-05 | 194 | 83 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-05 | 194 | 83 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.13e-05 | 194 | 83 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 195 | 83 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 195 | 83 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 195 | 83 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.21e-05 | 195 | 83 | 5 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 195 | 83 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.29e-05 | 196 | 83 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.29e-05 | 196 | 83 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-05 | 197 | 83 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-05 | 197 | 83 | 5 | 9b038dac4d4d306aa40ec07d79374c4fe9c604a6 | |
| ToppCell | C_01|World / shred on cell type and cluster | 3.45e-05 | 198 | 83 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-05 | 200 | 83 | 5 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.62e-05 | 200 | 83 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-05 | 200 | 83 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.62e-05 | 200 | 83 | 5 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class | 3.62e-05 | 200 | 83 | 5 | c34fff02992cba6bcc2308019cb00b94e1227300 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.01e-05 | 122 | 83 | 4 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.27e-05 | 123 | 83 | 4 | e0130010aa406d4e9d8f16ad32858c382277eeb2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-04 | 144 | 83 | 4 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 146 | 83 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 148 | 83 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 148 | 83 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-04 | 149 | 83 | 4 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-04 | 149 | 83 | 4 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-04 | 151 | 83 | 4 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 59 | 83 | 3 | d49a63218a045f3d032d135aee234a3269222abd | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Rgs12_(Fast-spiking_interneuron,_Pvalb+/Rgs12+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 59 | 83 | 3 | 2d77ae08fa9836bbae158a0e466806a5f9236b5e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 154 | 83 | 4 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 154 | 83 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 154 | 83 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 154 | 83 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.27e-06 | 193 | 82 | 7 | 5437_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 6.71e-06 | 195 | 82 | 7 | 5665_UP | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | 7.41e-06 | 198 | 82 | 7 | 5067_UP | |
| Drug | b-3p | 7.51e-06 | 35 | 82 | 4 | CID000125132 | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 7.66e-06 | 199 | 82 | 7 | 2683_DN | |
| Drug | K 81 | 1.28e-05 | 2 | 82 | 2 | CID005744870 | |
| Drug | Candoxatril | 1.28e-05 | 2 | 82 | 2 | DB00616 | |
| Drug | I 591 | 1.28e-05 | 2 | 82 | 2 | CID000006458 | |
| Drug | 5-phenylproline | 1.28e-05 | 2 | 82 | 2 | CID000409781 | |
| Drug | acetol phosphate | 3.84e-05 | 3 | 82 | 2 | CID000150865 | |
| Drug | 4-hydroxy-9-fluorenone | 3.84e-05 | 3 | 82 | 2 | CID000016139 | |
| Drug | Htfp | 3.84e-05 | 3 | 82 | 2 | CID000125055 | |
| Drug | DIDIT | 3.84e-05 | 3 | 82 | 2 | CID000196082 | |
| Drug | BP1.137 | 3.84e-05 | 3 | 82 | 2 | CID005311337 | |
| Drug | 2-keto-3-deoxy- l-lyxonate | 3.84e-05 | 3 | 82 | 2 | CID000192781 | |
| Drug | androisoxazole | 3.84e-05 | 3 | 82 | 2 | CID000009676 | |
| Drug | 2-keto-3-bromobutyrate | 3.84e-05 | 3 | 82 | 2 | CID000191968 | |
| Drug | 3-isochromanone | 3.84e-05 | 3 | 82 | 2 | CID000078092 | |
| Drug | 5-deoxy-5-fluoro-L-sorbose | 3.84e-05 | 3 | 82 | 2 | CID000191809 | |
| Drug | D-ribulose-1-p | 3.84e-05 | 3 | 82 | 2 | CID000000615 | |
| Drug | aladotril | 3.84e-05 | 3 | 82 | 2 | CID006450804 | |
| Drug | aladotrilat | 3.84e-05 | 3 | 82 | 2 | CID006450805 | |
| Drug | 4-hydroxy-2-ketopimelate | 3.84e-05 | 3 | 82 | 2 | CID000000553 | |
| Drug | AC1L19F1 | 3.84e-05 | 3 | 82 | 2 | CID000000519 | |
| Drug | malonate semialdehyde | 4.19e-05 | 19 | 82 | 3 | CID000000868 | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A | 7.45e-05 | 195 | 82 | 6 | 4106_DN | |
| Drug | formylacetate | 7.65e-05 | 4 | 82 | 2 | CID000075269 | |
| Drug | dihydroxyacetone sulfate | 7.65e-05 | 4 | 82 | 2 | CID000439751 | |
| Drug | C06441 | 7.65e-05 | 4 | 82 | 2 | CID000441020 | |
| Drug | glycopril | 7.65e-05 | 4 | 82 | 2 | CID000131848 | |
| Drug | 3-hydroxy-1-indanone | 7.65e-05 | 4 | 82 | 2 | CID000176448 | |
| Drug | l-123 | 7.65e-05 | 4 | 82 | 2 | CID000093552 | |
| Drug | NSC-701765 | 7.65e-05 | 4 | 82 | 2 | CID000396210 | |
| Drug | omapatrilat | 7.65e-05 | 4 | 82 | 2 | ctd:C106266 | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 4578_UP | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A | 7.67e-05 | 196 | 82 | 6 | 1367_DN | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 3132_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 3742_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 6445_DN | |
| Drug | hydroxyl radicals | ABAT PDE4C GLB1 PTPRK MAN1C1 COX6A2 USP40 CYP7B1 MME GLB1L2 PTPRU ACE ATP2A1 CIT CYP2W1 | 7.86e-05 | 1341 | 82 | 15 | CID000000961 |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 6472_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 4392_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 2980_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; HL60; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 2579_DN | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 3805_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 2989_DN | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 1229_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; PC3; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 4606_UP | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; HL60; HG-U133A | 8.57e-05 | 200 | 82 | 6 | 1730_UP | |
| Drug | AC1L2T2K | 1.10e-04 | 26 | 82 | 3 | CID000128038 | |
| Drug | oxalocrotonate | 1.10e-04 | 26 | 82 | 3 | CID000440019 | |
| Drug | Tgg Tripeptide | 1.24e-04 | 27 | 82 | 3 | CID000123715 | |
| Drug | 1,3-dioxan-5-one | 1.27e-04 | 5 | 82 | 2 | CID009793707 | |
| Drug | AC1L4F2K | 1.27e-04 | 5 | 82 | 2 | CID000184526 | |
| Drug | BMS-189921 | 1.27e-04 | 5 | 82 | 2 | CID000172318 | |
| Drug | gamma-oxalocitramalate | 1.27e-04 | 5 | 82 | 2 | CID000000130 | |
| Drug | 2,3-dihydroxy-p-cumate | 1.27e-04 | 5 | 82 | 2 | CID000029587 | |
| Drug | AC1NX490 | 1.27e-04 | 5 | 82 | 2 | CID005743230 | |
| Drug | Bl 19 | 1.27e-04 | 5 | 82 | 2 | CID003083138 | |
| Drug | phosphoglycollamide | 1.27e-04 | 5 | 82 | 2 | CID000191768 | |
| Drug | D-erythrulose 1-phosphate | 1.27e-04 | 5 | 82 | 2 | CID000152153 | |
| Drug | S-11-P | 1.27e-04 | 5 | 82 | 2 | CID000194428 | |
| Drug | hydroxypyruvaldehyde phosphate | 1.27e-04 | 5 | 82 | 2 | CID000193787 | |
| Drug | tauroursocholate | 1.86e-04 | 146 | 82 | 5 | CID000005246 | |
| Drug | mycestericin D | 1.90e-04 | 6 | 82 | 2 | CID006439504 | |
| Drug | GABOB | 1.90e-04 | 6 | 82 | 2 | CID000002149 | |
| Drug | C02783 | 1.90e-04 | 6 | 82 | 2 | CID000439805 | |
| Drug | SQ 29,072 | 1.90e-04 | 6 | 82 | 2 | CID000129608 | |
| Drug | 2,2-dimethyl-1,3-dioxan-5-one | 1.90e-04 | 6 | 82 | 2 | CID002733141 | |
| Drug | 2-(N-decyl)aminonaphthalene-6-sulfonic acid | 1.90e-04 | 6 | 82 | 2 | CID000189836 | |
| Drug | parapyruvate | 1.90e-04 | 6 | 82 | 2 | CID000440249 | |
| Drug | acetyldithio-CoA | 1.90e-04 | 6 | 82 | 2 | CID003082679 | |
| Drug | 0 Gz | 1.90e-04 | 6 | 82 | 2 | CID000000372 | |
| Drug | chloroacetol phosphate | 1.90e-04 | 6 | 82 | 2 | CID000168137 | |
| Drug | EMCs | 2.49e-04 | 34 | 82 | 3 | CID005091655 | |
| Drug | acenaphthenone | 2.66e-04 | 7 | 82 | 2 | CID000075229 | |
| Drug | DAPpNP | 2.66e-04 | 7 | 82 | 2 | CID005492375 | |
| Drug | CGS 35601 | 2.66e-04 | 7 | 82 | 2 | ctd:C511403 | |
| Drug | 5-deoxy-D-xylulose-1-phosphate | 2.66e-04 | 7 | 82 | 2 | CID000192931 | |
| Drug | Z-Glu-Tyr | 2.66e-04 | 7 | 82 | 2 | CID000096820 | |
| Drug | C0447 | 2.66e-04 | 7 | 82 | 2 | CID000128786 | |
| Drug | meprobamate | 2.90e-04 | 88 | 82 | 4 | CID000004064 | |
| Disease | Autosomal Dominant Lateral Temporal Lobe Epilepsy | 2.23e-05 | 3 | 81 | 2 | C1838062 | |
| Disease | periostin measurement | 4.45e-05 | 4 | 81 | 2 | EFO_0020628 | |
| Disease | leukemia (is_implicated_in) | 5.69e-04 | 13 | 81 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | neutrophil collagenase measurement | 8.71e-04 | 16 | 81 | 2 | EFO_0008248 | |
| Disease | Renal Insufficiency | 9.85e-04 | 17 | 81 | 2 | C1565489 | |
| Disease | ischemia (implicated_via_orthology) | 9.85e-04 | 17 | 81 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | lung cancer (is_implicated_in) | 1.12e-03 | 74 | 81 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Hodgkins lymphoma | 1.51e-03 | 82 | 81 | 3 | EFO_0000183 | |
| Disease | Kidney Failure | 1.66e-03 | 22 | 81 | 2 | C0035078 | |
| Disease | nephrosis (biomarker_via_orthology) | 1.66e-03 | 22 | 81 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | corpus callosum central volume measurement | 2.69e-03 | 28 | 81 | 2 | EFO_0010296 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.69e-03 | 28 | 81 | 2 | DOID:12236 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCFQWYIPPLDRPPK | 2931 | Q96N23 | |
| YRAFVPLLKNPEPWL | 91 | A6NEN9 | |
| WSLRLKYQGLCPPVP | 1091 | P12821 | |
| NGYWALTPLRTPLPL | 401 | Q13410 | |
| LPPSLKIYSWKRPQD | 91 | Q8N7X0 | |
| PLPRPWALTFSYGRA | 291 | P09972 | |
| PLPKPWKLSFSYGRA | 291 | P05062 | |
| LETIWRFSPGLPGYP | 161 | Q9H8M1 | |
| PNFRYPWSIPFTLKP | 436 | Q9BYG8 | |
| ELSLWKPTGPANIYP | 801 | Q5H9F3 | |
| YRGRPFPLALLGWAP | 161 | Q8TAV3 | |
| LIPGTFGLRKPWYFP | 3776 | Q86UQ4 | |
| WPGRTLYLLAPSFPD | 1536 | O14578 | |
| PRSPKEPLISGWLFF | 821 | O14983 | |
| KPRPTYRWLKNGVPL | 416 | O94779 | |
| AYPPPRISWLKNNLT | 341 | P16234 | |
| LYPSILTFPWQPKTG | 456 | Q8TEM1 | |
| FLLPWLPSRPASYAS | 1311 | O75140 | |
| LVLFGGWTRPSPYPL | 186 | Q6P3S6 | |
| SLGWLPIQLTPFYPV | 351 | Q9Y215 | |
| FWPPQPKLYKVGLGL | 721 | Q13045 | |
| PEALAFKWPFLGPRQ | 301 | O75610 | |
| WYQQKPGSLPRYLLR | 56 | A0A0G2JS06 | |
| FDWPIAPFPRLKYPL | 241 | P80404 | |
| YWPARGPQLTLFVPQ | 591 | P16278 | |
| LYFRPTIQRGQWPPG | 131 | O00443 | |
| DLSNPTKPLPLYRQW | 546 | Q08493 | |
| PWLGLPAVPAVTLYK | 301 | Q6P996 | |
| PWLGLPAVPAVTLYK | 301 | Q6P474 | |
| PLLKLLPDIYGWPVA | 156 | P08473 | |
| TKLLTKGLSWQPPPY | 1106 | Q7Z6Z7 | |
| IWSPPTAPNDLYLKL | 116 | Q8NFU5 | |
| NKWTRITLPLPPYTR | 2436 | P78509 | |
| FPTKGWKRITYPLPE | 2811 | P78509 | |
| QTYRGFWNPPLEPRK | 686 | Q92729 | |
| IAYIYPWRRNGPLPL | 211 | P35227 | |
| SWYPKLFPLSCPPLR | 41 | Q96A11 | |
| PALWSNTAYPSLKPL | 3946 | Q9C0G6 | |
| SKRLWGLVPFGLYLP | 1141 | Q9H799 | |
| PYQHLRIRTKPYPWG | 61 | Q02221 | |
| LQWLPGTAYLRRPVP | 181 | Q495W5 | |
| RSRPKLWSAIPPYNA | 31 | A8MV24 | |
| TYSIEIPKPPWLGFL | 86 | Q6MZM0 | |
| PASPWGLRLPQKFLF | 11 | Q9NR34 | |
| PGQPPKLLIYWASTR | 66 | P06312 | |
| LGPKPTFWPLFREQL | 1296 | Q8IWT3 | |
| ALPYWVPLSLRPRKQ | 96 | Q9H693 | |
| PPLIKGWLPYLGVVL | 46 | O75881 | |
| PQKTLYLPGPWLSSG | 591 | Q8IW92 | |
| WRPYLSQLKTPIPVT | 3406 | Q9NYC9 | |
| YPLLPQEGTSVLPFW | 266 | Q9BRP7 | |
| PIRDSWSKYFVPPQL | 256 | Q6ZMB0 | |
| LGFPSPPLVQLIFWS | 61 | Q6ZPB5 | |
| PVFWSQRPNLKYKPL | 261 | Q9NTJ5 | |
| SQKTTPLPRYLWPGH | 6 | P51172 | |
| SYFRAQGWAPLKPLP | 511 | Q99829 | |
| RTYQGFWNPPLAPRK | 691 | Q15262 | |
| REPLYDLPWYSKLPP | 86 | Q9GZV8 | |
| PDPSRLPLVASWKTY | 251 | Q495M3 | |
| GIIKLGRWNPLPLSY | 116 | Q9UPW6 | |
| WFPYDGSKLPLRPKR | 41 | Q6ZNX1 | |
| LLLAPPGLAWYKPAA | 16 | Q8NG41 | |
| FPGWVYQPRPGKRKR | 401 | O94993 | |
| LWGLPYGSLPRKTVP | 216 | Q8TDI8 | |
| SSWVSRGPDKLLPYP | 231 | P0C1Z6 | |
| LPSWAELLRPKYRAP | 571 | Q96AQ6 | |
| ALYPPWRGVLGPLLV | 91 | Q03395 | |
| APPGPKLWYRDFLQL | 681 | Q13214 | |
| FPWQGPRTLLLYKSP | 36 | Q9P227 | |
| LLAAVPFWYLPKSLP | 286 | Q9NYB5 | |
| PFWYLPKSLPRSQSR | 291 | Q9NYB5 | |
| KWGSVSNPLFLPLIP | 436 | Q93063 | |
| FPRLPGKWPFSLSEQ | 216 | Q96L92 | |
| AWPLSKLGPFTVLLP | 396 | Q8WWQ8 | |
| PQWYPARQSLRLDPK | 41 | Q9NZ01 | |
| RKIPYPTKNPFTWLF | 226 | Q9NZ01 | |
| YPFNPPKVRFITKIW | 66 | P61086 | |
| IEILPLKGYFPSNWP | 1511 | Q86YA3 | |
| PPTPQGQASRWLFLF | 86 | Q8N9X3 | |
| LWLRRYGNLKSPEPP | 686 | Q8TEQ8 | |
| TPLNWLVGPFYPQLT | 396 | Q99541 | |
| WPPFLRGLRYLHPLK | 141 | Q7RTU1 | |
| LPPLGFLKVPIWWYQ | 926 | Q9NVE5 | |
| PRRWTPYPSQKTLDL | 346 | Q9H2Y7 | |
| QPAPPGSLELLLYFW | 806 | Q8TD43 | |
| PPYLFGILIQKWETP | 1051 | O95405 | |
| PFNVIPSPKSLWYLI | 656 | Q9UBN4 | |
| SGNFYIWRPLRIPLK | 41 | Q8IWR1 | |
| SLSPIDKNWPSRPYL | 891 | O43795 |